B+
Bull case
20%
Probability
Target price
$88.77
Analysis reference price unavailable
Analysis 2026-01-10 · RankAlpha Sentiment AI
CGON
CG OncologyDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Successful clinical readouts or a strategic partnership could rapidly re-rate the stock toward premium growth multiples; market attention would likely amplify upside given limited public float and concentrated event risk [#SERP-1].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -0.4.
What can break
Clinical readout failure or delay
Momentum
27
Value
41
Sentiment
63
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $63.80 · Bull $88.77 · Bear $38.84Analysis 2026-01-10; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-29 • Vendor: Data Vendor v1
Scores
As of 2026-10-29 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-10 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-10-29
Investment thesis
As of 2026-10-29
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-29. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $91.08
Why
Momentum27 · Δ7d +11.2
Value41 · Δ7d -0.1
Sentiment63 · Δ7d -0.4
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -0.4.
Contradictions & invalidation
- • Clinical readout failure or delay
- • Insufficient cash runway / dilutive financing
- • Negative trial outcomes, missed operational guidance, or a short cash runway would materially compress valuation and push the share price below current levels; small-cap biotech downside tends to be abrupt on binary failures [#SERP-2].
Catalyst clock
2026-03-31
Clinical data readout (assumed window end)
Lead driver: Sentiment · See AI snapshot
Momentum
27
8% active weight
Current posture
7d trendImproving
Δ7d
+11.2
Δ21d
-26.2
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.2
Sentiment
63
45% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-4.1
Why this grade
Composite grade D. Momentum 27.1 / Value 40.7 / Sentiment 62.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-10. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$63.80
Analysis reference price unavailable
Analysis 2026-01-10 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$38.84
Analysis reference price unavailable
Analysis 2026-01-10 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-10-29
Fundamentals (TTM)
As of 2026-10-29
Market Cap
$5.63B
Beta
-
Shares Out
88.64M
P/E (TTM) · Derived
-30.5
P/S (TTM)
1485.68
P/FCF (TTM) · Derived
-29.26
Rev YoY
+1982.7%
EPS YoY
+64.9%
Gross Margin
-93.3%
Op Margin
-4056.2%
Net Debt
-$735.13M
Current Ratio
22.22
As of 2026-10-29 • Updated nightlySource: Internal modelMethods & Data